Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Preferred Stock Liabilities (2019 - 2020)

Biodesix's Preferred Stock Liabilities history spans 2 years, with the latest figure at $194.0 million for Q3 2020.

  • For Q3 2020, Preferred Stock Liabilities changed 0.0% year-over-year to $194.0 million; the TTM value through Sep 2020 reached $194.0 million, changed 0.0%, while the annual FY2019 figure was $194.0 million, N/A changed from the prior year.
  • Preferred Stock Liabilities reached $194.0 million in Q3 2020 per BDSX's latest filing, roughly flat from $194.0 million in the prior quarter.
  • In the past five years, Preferred Stock Liabilities ranged from a high of $194.0 million in Q3 2019 to a low of $194.0 million in Q3 2019.